Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab.

Author
:
L Pizzuti
D Sergi
I Sperduti
LD Lauro
M Mazzotta
C Botti
F Izzo
L Marchetti
S Tomao
P Marchetti
C Natoli
A Grassadonia
T Gamucci
L Mentuccia
E Magnolfi
A Vaccaro
A Cassano
E Rossi
A Botticelli
Sini V
MG Sarobba
MA Fabbri
L Moscetti
A Astone
A Michelotti
C De Angelis
I Bertolini
F Angelini
G Ciliberto
M Maugeri-Saccà
A Giordano
M Barba
P Vici
Year of Publication
:
2018
Journal
:
Cancer biology & therapy
Number of Pages
:
0
Date Published
:
2018
ISSN Number
:
1538-4047
DOI
:
10.1080/15384047.2017.1416938
Short Title
:
Cancer Biol Ther
Download citation